IBB Share Price Performance
Recent IBB News & Updates
No updates
iShares Trust - iShares Biotechnology ETF Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -9.40
- Gross Margin
- 100.00%
- Net Profit Margin
- -808.66%
- Debt/Equity Ratio
- 13.7%
iShares Trust - iShares Biotechnology ETF Competitors
About IBB
- Founded
- 2001
- Employees
- n/a
- CEO
- WebsiteView website
iShares Trust - iShares Biotechnology ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States. It invests in stocks of companies operating across biotechnology sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE Biotechnology Index, by using representative sampling technique. iShares Trust - iShares Biotechnology ETF was formed on February 5, 2001 and is domiciled in the United States.
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 10.7%
- 1 Year: 17.5%
- Year to Date: 5.9%
The market has dropped by 18% in the last 7 days, with the Financials sector leading declines. In contrast to the last week, the market is actually up 18% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading